State Of Wyoming Horizon Therapeutics Public LTD CO Transaction History

State Of Wyoming

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $199,829 - $211,337	1,862 New	1,862 $203,000
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $161,676 - $232,334	2,744 Added 648.7%	3,167 $196,000
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $30,489 - $44,682	384 Added 984.62%	423 $34,000
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $604 - $768	7 Added 21.88%	39 $4,000
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $295 - $359	-3 Reduced 8.57%	32 $3,000
Q3 2021 Feb 11, 2022	SELL	$91.91 - $110.37 $1,470 - $1,765	-16 Reduced 31.37%	35 $4,000
Q2 2021 Feb 11, 2022	BUY	$86.24 - $95.92 $2,328 - $2,589	27 Added 112.5%	51 $5,000
Q1 2021 Feb 08, 2022	BUY	$71.83 - $95.48 $1,723 - $2,291	24 New	24 $2,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.